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Introduction 
Diabetes mellitus (DM) and its 
complications remain a global challenge to 
health care systems. Diabetic myonecrosis is 
a rare and under-diagnosed complication of 
DM that was first reported in 1965.1 
Diabetic myonecrosis affects patients with 
poorly controlled and longstanding type 1 
diabetes mellitus (DM) and associated 
microvascular complications.2 Recently, 
diabetic myonecrosis also has been reported 
in type 2 diabetes mellitus patients.3 
Elevation of muscle enzymes such as 
creatine phosphokinase (CPK) is present in 
half of all cases of diabetic myonecrosis. It 
can be misdiagnosed as cellulitis, 
inflammatory myopathy, deep vein 
thrombosis or fasciitis.4 The diagnosis is 
based on the constellation of clinical, 
laboratory, imaging, and pathological 
findings. It is usually self-limited and 
responds well to conservative management 
if diagnosed early.5 The short-term 
prognosis is usually good with slow 
recovery. Failure to recognize this condition 
can result in significant morbidity. 
Physicians should consider diabetic 
myonecrosis in the differential diagnosis of 
acute focal myalgia in a diabetic patient. We 
report two cases of diabetic myonecrosis in 
patients with type 2 diabetes mellitus. 
Case Report 
Our first case was a thirty-six-year old 
male with history of type 2 diabetes mellitus 
who had been diagnosed within the past six 
months and treated with oral hypoglycemic 
agents. He presented with bilateral thigh 
pain of two-month duration. The pain had 
worsened with progressive swelling of both 
thighs. The swelling was acute in onset and 
located diffusely over the thighs which 
severely impaired him from performing 
activities of daily living. The patient denied 
any history of trauma, intramuscular 
injections, infections, or drug abuse. He had 
similar history of pain and swelling in the 
right thigh five months prior, which resolved 
spontaneously. Medical records revealed 
that the patient was noncompliant and his 
diabetes was poorly controlled. 
On examination, his vital signs were 
stable. He had a body mass index (BMI) of 
29.3 kg/m2. The physical examination 
revealed bilateral pitting pedal edema and 
diffuse swelling of the anterior, medial, and 
postero-lateral regions of the thigh along 
with induration and tenderness, but no 
inflammation, fluctuation, or crepitus. 
Peripheral pulses were palpable in the lower 
extremities. There was no focal weakness or 
sensory loss. Deep tendon reflexes were 
normal in all four limbs. The laboratory 
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studies included normal complete blood 
count with differential, serum creatinine, 
alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), lactate 
dehydrogenase (LDH) and thyroid 
stimulating hormone (TSH). His abnormal 
labs included a creatine phosphokinase 
(CPK) of 2531 IU/L (normal range 32-162), 
erythrocyte sedimentation rate (ESR) of 140 
mm/h, C-reactive protein (CRP) of 25.6 
mg/l, and hemoglobin A1c of 13.5%. 
Autoimmune serologies were normal or 
negative including anti-nuclear antigen 
(ANA), extractable nuclear antibodies, 
double stranded DNA, Jo-1, and serum 
complements. Radiographic studies of both 
the thighs and knees were unremarkable. 
A Doppler ultrasonography of bilateral 
lower extremities did not reveal a deep 
venous thrombosis (DVT) or a collection of 
fluid in the muscle planes, but there was 
subcutaneous edema. Magnetic resonance 
imaging (MRI) of the bilateral thighs 
demonstrated high signal intensity on T2-
weighted images showing diffuse 
myoedema and focal myonecrosis bilaterally 
and subcutaneous edema of the anteromedial 
compartment in the right thigh and the 
posterior medial compartment of the left 
thigh (Figures 1 and 2). A diagnosis of 
diabetic myonecrosis was made based on 
clinical presentation, negative 
immunological markers, ultrasound, and 
characteristic MRI findings. Management 
with bed rest, limb elevation, insulin therapy 
and analgesics was initiated. His pain and 
swelling improved significantly without the 
need for further evaluation, such as muscle 
biopsy. At the time of discharge, the patient 
was able to ambulate with assistance. 
 
 
 
 
 
 
Figure 1. Coronal T2 fat saturation image shows 
diffuse increased muscle signal and edema bilaterally 
(long arrow), with areas of normal muscle signal 
(short arrow). There is also diffuse subcutaneous 
stranding and edema, as well as perifascicular fluid 
(arrowhead). 
 
Figure 2. Axial T2 image in the same patient shows 
diffuse increased T2 signal consistent with muscle 
edema in the anterior compartment of the left thigh 
(long arrow) with normal muscle signal in the 
posterior compartment (short arrow). There is a small 
amount of perifascicular fluid (arrowhead). 
 
The second case was a 48-year-old 
morbidly obese female with uncontrolled 
diabetes mellitus type 2 with complications 
of end-organ damage. The patient was 
admitted to the hospital with complaints of 
acute onset right thigh pain and swelling. 
She was afebrile on physical examination. 
There was a well-defined erythematous area 
of induration on the right posterior lateral 
thigh. Her right leg had a mottled 
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appearance with evidence of pitting edema. 
Pain was elicited on palpation of the right 
lower extremity. Muscle strength was intact. 
She had limited range of motion on 
flexion/extension of the knee and difficulty 
with weight-bearing activities on the right 
lower extremity due to pain. She had 
decrease sensation in her lower extremities 
distally secondary to known diabetic 
neuropathy. Peripheral pulses were intact.  
Venous Doppler of the right lower 
extremity showed scarring associated with 
her previous DVT and a popliteal cyst. MRI 
imaging of the right thigh showed multiple 
areas of abnormal signal and contrast 
enhancement involving the muscles of the 
right thigh consistent with muscle infarcts 
(Figures 3 and 4). A punch biopsy of the 
area of erythema and induration revealed 
subcutaneous fat necrosis and trace dermal 
fibrin deposition. There was no evidence of 
infection on skin biopsy staining and 
culture. Abnormal laboratory studies 
included an elevated CPK of 7,491 IU/L, 
CRP 3.81 mg/dl, ESR 22 mm/h, and 
hemoglobin A1c of 7.7%. All other studies, 
such as thyroid function and autoimmune 
serologies to exclude an inflammatory 
myopathy, were negative. 
The decision was made to wait for a 
muscle biopsy to reduce the potential for 
limb threatening complications due to need 
for a wide surgical debridement. The 
diagnosis of diabetic myonecrosis was 
established based on history, clinical 
examination, laboratory, and imaging 
studies.  
The patient’s symptoms and findings 
improved following pain control, bed rest, 
and better glycemic control. She presented 
to the outpatient internal medicine clinic 
eight weeks post-discharge with complete 
resolution of her thigh pain and swelling. 
 
 
 
 
Figure 3. Coronal T1 fat saturation post contrast 
image shows diffuse scattered muscle enhancement 
(arrowheads), with areas of normal muscle (short 
arrow). There is a focal area of non enhancing muscle 
with peripheral rim like enhancement in the right 
thigh consistent with muscle infarction (long arrow). 
 
Figure 4. Axial T1 fat saturation post contrast image 
in the same patient shows diffuse increased signal 
consistent with enhancement in the anterior 
compartment of the thigh (arrowheads) compared to 
the normal muscle in the posterior compartment 
(short arrow). There is a focal area of non-enhancing 
muscle with peripheral enhancement in the anterior 
compartment consistent with infarction (long 
arrows).  
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Discussion 
Diabetic myonecrosis is an uncommon 
complication of a long-standing and poorly 
controlled DM.2 The majority of patients 
have diabetic end-organ damage such as 
retinopathy, neuropathy, and nephropathy.3 
Since it was first described in 1965, less 
than one hundred cases have been reported.1 
In most of these cases, diagnosis was 
delayed because of failure to recognize this 
condition.4 Diabetes myonecrosis is more 
prevalent in women (61.5%) with mean age 
at presentation of 42.6 years, and mean 
duration of diabetes of 14.3 years.5 
Typically, it involves the thigh, but it can 
extend to the calf as well (19.2%).5 Among 
the thigh muscles, it has a predilection for 
the quadriceps (62%, especially vastus 
medialis), hip adductors (13%), hamstrings 
(8%), and hip flexors (2%).6 Rarely, can it 
involve the upper extremities and paraspinal 
muscles.7-9 
The pathogenesis of this disease is 
unclear. Several hypotheses have been 
suggested. Muscle infarction could be 
caused by atherosclerosis and diabetic 
microangiopathy leading to ischemia of the 
muscle resulting in an intense inflammatory 
response, edema, hyperemia, and 
reperfusion. This generates oxygen-free 
radicals and increased pressure in the fascial 
compartment leading to muscle infarction.10 
Another hypothesis points to an alteration in 
the coagulation-fibrinolysis system as the 
cause of diabetic muscle infarction, as 
described by Palmer and Greco.11 Gargiulo 
et al.12 implicated a role for antiphospholipid 
antibodies in the progression of diabetes 
complications. Myonecrosis may occur in 
other disease states that predispose to 
peripheral vascular occlusion such as 
vasculitis, thromboembolism, trauma, 
compartment syndrome, and 
calciphylaxis.13,14 
Patients with diabetic myonecrosis 
usually complain of abrupt onset of severe 
leg pain in the medial aspect of the anterior 
thigh. The pain is diffuse and may radiate to 
surrounding structures such as the low back, 
knees, and calves. The pain usually worsens 
over days to weeks. Examination early in the 
course reveals diffuse tenderness and 
swelling, which after several weeks may 
develop into a firm, discrete, and fusiform 
mass-like appearance. Pulses usually are 
palpable in the extremities and there are no 
signs of gangrene. Strength and sensation 
are unaffected, but movement may be 
limited due to pain.14 
CPK levels may be elevated over three 
to four-fold and may become normal when 
the patients are tested after improvement of 
the acute event. Aldolase, aspartate 
aminotransferase (AST), alanine 
aminotransferase (ALT), and lactate 
dehydrogenase (LDH) levels may be 
elevated.  The white blood cell count (WBC) 
typically is normal and erythrocyte 
sedimentation rate (ESR) may be quite 
elevated (50-150 mm/h).15 
The most effective diagnostic modality 
in diabetic myonecrosis is MRI. The typical 
features of MRI in diabetic myonecrosis are 
high intensity signal on T2 weighted-images 
with marked muscle edema extending to the 
perifascicular and subcutaneous tissues.1,13,16 
Muscle biopsy is the gold standard 
diagnostic procedure. However, based on 
literature review and clinical experience, the 
muscle biopsy could be reserved for cases in 
which the clinical presentation is atypical or 
the diagnosis is uncertain, as well as when 
appropriate treatment fails to elicit 
improvement.17 Additionally, muscle biopsy 
or surgical excision either could prolong the 
disease or acutely exacerbate the 
condition.18 Usually MRI, clinical 
examination, patient history, and a 
reasonable exclusion of other etiologies 
suffice in securing the diagnosis. Other 
diagnostic tools that may be considered 
include Duplex venous ultrasound, 
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computed tomography scan (CT), bone 
scintigraphy, venogram, angiography, and 
electromyography (EMG).15,19 Deep vein 
thrombosis ranks highest on the differential 
diagnosis of diabetic myonecrosis of the 
extremities, so Duplex venous ultrasound 
commonly is used to exclude deep vein 
thrombosis. 
Other differential diagnoses of 
myonecrosis include cellulitis, compartment 
syndrome, superficial thrombophlebitis, 
necrotizing fasciitis, abscess, hematoma, 
pyomyositis, osteomyelitis, tumors (benign 
and malignant including sarcomas), 
dermatomyositis, proliferative or focal 
myositis, parasitic myositis, ruptured 
Baker’s cyst, diabetic amyotrophy, muscle 
strain, exertional muscle rupture, bursitis, 
vasculitis, lymphedema, amyloidosis, 
sarcoidosis, myositis ossificans, drug related 
myositis (statin group) and bone 
fracture.2,3,14,18,20,21,22 In the cases presented 
here, the differential diagnoses were 
excluded by the history, clinical 
examination, laboratory, and imaging 
investigations.  
Treatment of diabetic myonecrosis 
includes adequate bed rest, short-term 
immobilization, analgesics (nonsteroidal 
anti-inflammatory medications, narcotics, or 
both), and most importantly optimal 
glycemic control. Some authors propose the 
use of antiplatelet therapy to treat the 
underlying microvasculopathy, although this 
has not been established as a standard of 
care.22,23 Exercise or physical therapy 
exacerbates pain and extends infarction, thus 
is discouraged in the acute setting.18,21 The 
long-term prognosis, especially when 
diagnosis and management are delayed, can 
be poor and recurrence rate could be as high 
as 50% with 8-9% involving the originally 
affected muscles and 39% involving other 
muscles. However, the short-term prognosis 
is good with supportive care and following 
tight glycemic control. Overall, patients with 
diabetic myonecrosis could have a poor 
prognosis, and most patients die within five 
years of diagnosis due to end-organ 
microvascular complications.10,14,15 
 
Conclusion 
Diabetic myonecrosis should be 
considered in diabetic patients who develop 
a painful and swollen muscle. It is a 
manifestation of poor glycemic control, and 
a marker of underlying progressive 
microvascular disease. Patients with diabetic 
myonecrosis should undergo evaluation for 
potential complications of diabetes, 
including retinopathy, nephropathy, 
neuropathy and atherosclerosis. Diabetic 
myonecrosis is another reminder that 
aggressive diabetic control is essential to 
prevent end-organ damage, morbidity and 
mortality. 
These two cases are unique as they 
describe patients with type 2 diabetes 
mellitus who suffered from involvement of 
bilateral thighs. 
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